Rochwerg, Bram;
Agarwal, Arnav;
Zeng, Linan;
Leo, Yee-Sin;
Appiah, John Adabie;
Agoritsas, Thomas;
Bartoszko, Jessica;
Brignardello-Petersen, Romina;
Ergan, Begum;
Ge, Long;
Geduld, Heike;
Gershengorn, Hayley B;
Manai, Hela;
Huang, Minhua;
Lamontagne, François;
Kanda, Seema;
Kawano-Dourado, Leticia;
Kurian, Linda;
Kwizera, Arthur;
Murthy, Srinivas;
Qadir, Nida;
Siemieniuk, Reed;
Silvestre, Maria Asuncion;
Vandvik, Per Olav;
Ye, Zhikang;
Zeraatkar, Dena;
Guyatt, Gordon.
Clinical question: What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.Remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19. Aft...
This guideline covers mental health rehabilitation for adults with complex psychosis. It aims to ensure people can have rehabilitation when they need it and promotes a positive approach to long-term recovery. It includes recommendations on organising rehabilitation services, assessment and care planning,...
A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/pathogénicité,
Infections à coronavirus/imagerie diagnostique,
Infections à coronavirus/complications,
Infections à coronavirus/traitement médicamenteux,
Pneumopathie virale/imagerie diagnostique,
Pneumopathie virale/traitement médicamenteux,
Pneumopathie virale/complications,
Pandémies/statistiques et données numériques,
Aggravation transitoire des symptômes,
Groupes à Risque,
Chine/épidémiologie,
Pneumonie associée aux soins/diagnostic,
Personnel de santé/organisation et administration,
État de porteur sain/transmission,
Transmission verticale de maladie infectieuse/prévention et contrôle
Be aware of the links between mental illness and obesity, and ensure you manage the weight gain side-effects of medications used in the treatment of mental illness.
Be aware that mental illness can impact obesity management efforts, and screen patients for potential mental illnesses that need to be a...
Solari, A;
Giordano, A;
Sastre-Garriga, J;
Köpke, S;
Rahn, A. C;
Kleiter, I;
Aleksovska, K;
Battaglia, M. A;
Bay, J;
Copetti, M;
Drulovic, J;
Kooij, L;
Mens, J;
Meza Murillo, E. R;
Milanov, I;
Milo, R;
Pekmezovic, T;
Vosburgh, J;
Silber, E;
Veronese, S;
Patti, F;
Voltz, R;
Oliver, D.
Background and purpose
Patients with severe, progressive multiple sclerosis (MS) have complex physical and psychosocial needs, typically over several years. Few treatment options are available to prevent or delay further clinical worsening in this population. The objective was to develop an evidence-base...
Moores, Lisa K;
Tritschler, Tobias;
Brosnahan, Shari;
Carrier, Marc;
Collen, Jacob F;
Doerschug, Kevin;
Holley, Aaron B;
Jimenez, David;
Gal, Gregoire Le;
Rali, Parth;
Wells, Philip.
Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition has led to the urgent need for practical guidance regarding prevention, diagnosis, and treatment of...
Falavigna, Maicon;
Colpani, Verônica;
Stein, Cinara;
Azevedo, Luciano César Pontes;
Bagattini, Ângela Maria;
Brito, Gabriela Vilela de;
Chatkin, José Miguel;
Cimerman, Sérgio;
Corradi, Mirian de Freitas Dal Ben;
Cunha, Clóvis Arns da;
Medeiros, Flávia Cordeiro de;
Oliveira Júnior, Haliton Alves de;
Fritscher , Leandro Genehr;
Gazzana, Marcelo Basso;
Graf, Débora Dalmas;
Marra, Lays Pires;
Matuoka , Jéssica Yumi;
Nunes, Michelle Silva;
Pachito, Daniela Vianna;
Pagano, Cássia Garcia Moraes;
Parreira, Patrícia do Carmo Silva;
Riera, Rachel;
Silva Júnior, Amilton;
Tavares, Bruno de Melo;
Zavascki, Alexandre Prehn;
Rosa, Régis Goulart;
Dal-Pizzol, Felipe.
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Infections à coronavirus/traitement médicamenteux,
Aminoquinoléines/usage thérapeutique,
Oséltamivir/usage thérapeutique,
Lopinavir/usage thérapeutique,
Ritonavir/usage thérapeutique,
Hormones corticosurrénaliennes/usage thérapeutique,
Héparine/usage thérapeutique,
Antibactériens/usage thérapeutique,
Betacoronavirus/effets des médicaments et des substances chimiques,
Pneumopathie virale/traitement médicamenteux,
Pandémies/prévention et contrôle
The writing group produced the draft guideline, which was subsequently revised by consensus. Review of the manuscript was performed by the BSH Guidelines Committee Haemostasis and Thrombosis Taskforce, the BSH Guidelines Committee and the Haemostasis and Thrombosis sounding board of the BSH. It was also ...
Dementia is one of the most common disorders and is associated with increased morbidity, mortality and decreased quality of life. The present guideline addresses important medical management issues including systematic medical follow-up, vascular risk factors in dementia, pain in dementia, use of antipsy...
The purpose of this guideline is to ensure the best antibiotic management of suspected or confirmed bacterial pneumonia in adults in hospital during the COVID‑19 pandemic. This includes people presenting to hospital with moderate to severe community-acquired pneumonia and people who develop pneumonia w...
